A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis

P Zisimopoulou, P Evangelakou, J Tzartos… - Journal of …, 2014 - Elsevier
Double-seronegative myasthenia gravis (dSN-MG, without detectable AChR and MuSK
antibodies) presents a serious gap in MG diagnosis and understanding. Recently …
被引用次数：314 相关文章

A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis

P Zisimopoulou, P Evangelakou… - Journal of …, 2014 - cris.maastrichtuniversity.nl
Double-seronegative myasthenia gravis (dSN-MG, without detectable AChR and MuSK
antibodies) presents a serious gap in MG diagnosis and understanding. Recently …

A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis

P Zisimopoulou, P Evangelakou… - Journal of …, 2014 - pubmed.ncbi.nlm.nih.gov
Double-seronegative myasthenia gravis (dSN-MG, without detectable AChR and MuSK
antibodies) presents a serious gap in MG diagnosis and understanding. Recently …

A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis.

P Zisimopoulou, P Evangelakou, J Tzartos… - Journal of …, 2013 - europepmc.org
Double-seronegative myasthenia gravis (dSN-MG, without detectable AChR and MuSK
antibodies) presents a serious gap in MG diagnosis and understanding. Recently …

A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis

P Zisimopoulou, P Evangelakou, J Tzartos… - Journal of …, 2014 - infona.pl
Double-seronegative myasthenia gravis (dSN-MG, without detectable AChR and MuSK
antibodies) presents a serious gap in MG diagnosis and understanding. Recently …

[引用][C] A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis

P ZISIMOPOULOU, P EVANGELAKOU… - Journal of …, 2014 - pascal-francis.inist.fr
Author ZISIMOPOULOU, P 1; EVANGELAKOU, P 1 2; SARUHAN-DIRESKENELI, G 6;
DURMUS, H 6; BRENNER, T 7; VAKNIN, A 7; BERRIH-AKNIN, S 8; FRENKIAN CUVELIER …

A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis

P ZISIMOPOULOU, P EVANGELAKOU… - Journal of …, 2014 - avesis.istanbul.edu.tr
Double-seronegative myasthenia gravis (dSN-MG, without detectable AChR and MuSK
antibodies) presents a serious gap in MG diagnosis and understanding. Recently …

A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis

P Zisimopoulou, P Evangelakou, J Tzartos… - Journal of …, 2014 - pure.unic.ac.cy
Double-seronegative myasthenia gravis (dSN-MG, without detectable AChR and MuSK
antibodies) presents a serious gap in MG diagnosis and understanding. Recently …

[引用][C] A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis

P Zisimopoulou, P Evangelakou, J Tzartos… - Journal of …, 2014 - cir.nii.ac.jp
A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in
myasthenia gravis | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …

A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis.

P Zisimopoulou, P Evangelakou, J Tzartos, K Lazaridis… - 2014 - cabidigitallibrary.org
Double-seronegative myasthenia gravis (dSN-MG, without detectable AChR and MuSK
antibodies) presents a serious gap in MG diagnosis and understanding. Recently …